Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial - Reuters

Reuters | April 28, 2026, 9:21 a.m. | Original
Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial Reuters
AI stocks slide after report sparks OpenAI growth concerns - Reuters Standard Chartered, BlackRock, OKX launch collateral framework for tokenised Treasury fund - Reuters